Literature DB >> 10878769

IVIAT: a novel method to identify microbial genes expressed specifically during human infections.

M Handfield1, L J Brady, A Progulske-Fox, J D Hillman.   

Abstract

In vivo induced antigen technology (IVIAT) is a novel technology that can quickly and easily identify in vivo induced genes in human infections, without the use of animal models. This technology is expected to facilitate the discovery of new targets for vaccines, antimicrobials and diagnostic strategies in a wide range of microbial pathogens.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10878769     DOI： 10.1016/s0966-842x(00)01775-3

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  30 in total

Review 1.  Information overload: assigning genetic functionality in the age of genomics and large-scale screening.

Authors:  D Scott Merrell; Andrew Camilli
Journal:  Trends Microbiol       Date:  2002-12       Impact factor: 17.079

2.  Identification of group A Streptococcus antigenic determinants upregulated in vivo.

Authors:  Kowthar Y Salim; Dennis G Cvitkovitch; Peter Chang; Darrin J Bast; Martin Handfield; Jeffrey D Hillman; Joyce C S de Azavedo
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection.

Authors:  Manohar John; Indira T Kudva; Robert W Griffin; Allen W Dodson; Bethany McManus; Bryan Krastins; David Sarracino; Ann Progulske-Fox; Jeffrey D Hillman; Martin Handfield; Phillip I Tarr; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Identification of Salmonella enterica serovar Pullorum antigenic determinants expressed in vivo.

Authors:  Qiuchun Li; Yachen Hu; Jing Chen; Zhicheng Liu; Jun Han; Lin Sun; Xinan Jiao
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

5.  Novel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesis.

Authors:  Yu-We Ku; Sean P McDonough; Raghavan U M Palaniappan; Chao-Fu Chang; Yung-Fu Chang
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Gene expression in Porphyromonas gingivalis after contact with human epithelial cells.

Authors:  Yumiko Hosogi; Margaret J Duncan
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT).

Authors:  Peter E Kima; J Alfredo Bonilla; Eumin Cho; Blaise Ndjamen; Johnathan Canton; Nicole Leal; Martin Handfield
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

8.  Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients.

Authors:  Young Ran Kim; Shee Eun Lee; Choon Mee Kim; Soo Young Kim; Eun Kyoung Shin; Dong Hyeon Shin; Sun Sik Chung; Hyon E Choy; Ann Progulske-Fox; Jeffrey D Hillman; Martin Handfield; Joon Haeng Rhee
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Analysis of a band 7/MEC-2 family gene of Porphyromonas gingivalis.

Authors:  S Walters; P Rodrigues; M Bélanger; J Whitlock; A Progulske-Fox
Journal:  J Dent Res       Date:  2009-01       Impact factor: 6.116

10.  Use of in vivo-induced antigen technology (IVIAT) for the identification of Streptococcus suis serotype 2 in vivo-induced bacterial protein antigens.

Authors:  Hongwei Gu; Haodan Zhu; Chengping Lu
Journal:  BMC Microbiol       Date:  2009-09-18       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.